Status: current, Primitive. Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4649401010 | Tivozanib hydrochloride | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4649402015 | Tivozanib hydrochloride (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tivozanib hydrochloride | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Tivozanib hydrochloride | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Tivozanib hydrochloride | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Tivozanib hydrochloride | Is a | Quinoline | true | Inferred relationship | Some | ||
| Tivozanib hydrochloride | Has disposition | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Tivozanib hydrochloride | Is modification of | Tivozanib | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tivozanib hydrochloride monohydrate | Is modification of | True | Tivozanib hydrochloride | Inferred relationship | Some | |
| Tivozanib (as tivozanib hydrochloride) 890 microgram oral capsule | Has precise active ingredient | True | Tivozanib hydrochloride | Inferred relationship | Some | 1 |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has precise active ingredient | True | Tivozanib hydrochloride | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR